A detailed history of Hikari Tsushin, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Hikari Tsushin, Inc. holds 23,512 shares of NVO stock, worth $2.47 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
23,512
Previous 23,512 -0.0%
Holding current value
$2.47 Million
Previous $3.36 Million 16.6%
% of portfolio
0.2%
Previous 0.26%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$87.78 - $105.45 $3.9 Million - $4.69 Million
-44,455 Reduced 65.41%
23,512 $2.43 Million
Q3 2023

Nov 08, 2023

BUY
$90.94 - $199.54 $454,427 - $997,101
4,997 Added 7.94%
67,967 $6.18 Million
Q1 2019

May 13, 2019

SELL
$46.36 - $52.63 $2.56 Million - $2.91 Million
-55,310 Reduced 46.76%
62,970 $3.29 Million
Q3 2018

Nov 15, 2018

SELL
$46.76 - $51.24 $935,200 - $1.02 Million
-20,000 Reduced 14.46%
118,280 $5.58 Million
Q2 2017

Sep 06, 2017

BUY
N/A
138,280
138,280 $5.93 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Hikari Tsushin, Inc. Portfolio

Follow Hikari Tsushin, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hikari Tsushin, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hikari Tsushin, Inc. with notifications on news.